Kantarci Orhun H, Hebrink David D, Achenbach Sara J, Atkinson Elizabeth J, Waliszewska Alicja, Buckle Guy, McMurray Cynthia T, de Andrade Mariza, Hafler David A, Weinshenker Brian G
Department of Neurology, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, MN 55905, USA.
J Neuroimmunol. 2003 Jan;134(1-2):133-41. doi: 10.1016/s0165-5728(02)00395-8.
We comprehensively screened CTLA4 for novel genetic variations in patients with MS. We studied genetic variations by association methods in a population-based sample of 122 sporadic patients with MS and 244 age-, gender- and ethnicity-matched controls, and by linkage and family-based association methods in 395 individuals from 59 American multiplex pedigrees with 141 affected individuals. Being homozygous for AT(8) (common) allele of the 3'(514) microsatellite (OR: 1.69; CI: 0.99-2.86) and for the common 5'(318)*C/E1(49)A/3'(514AT(8) haplotype (OR: 1.96; CI: 1.13-3.39) was associated with increased susceptibility to MS in Olmsted County. The genotype frequencies of other individual polymorphisms were not significantly different between cases and controls. A pooled analysis of association studies revealed an odds ratio of 1.28 (95% CI: 1.01-1.63; p=0.043) for 5'(-318)*C homozygotes and 1.28 (95% CI: 1.08-1.51; p=0.005) for the 3'(514)*AT(8) allele. We did not detect linkage with MS susceptibility in multiplex families. We did not find a strong association with age at onset, disease course or severity. CTLA-4 is associated with susceptibility to MS.
我们全面筛查了CTLA4在多发性硬化症(MS)患者中的新型基因变异。我们通过关联方法,在一个基于人群的样本中研究基因变异,该样本包括122例散发性MS患者和244名年龄、性别和种族匹配的对照;并通过连锁分析和基于家系的关联方法,对来自59个美国家系的395名个体进行研究,其中有141名受影响个体。3'(514)微卫星的AT(8)(常见)等位基因纯合子(比值比:1.69;可信区间:0.99 - 2.86)以及常见的5'(318)*C/E1(49)*A/3'(514)*AT(8)单倍型(比值比:1.96;可信区间:1.13 - 3.39)与奥姆斯特德县MS易感性增加相关。病例组和对照组之间其他个体多态性的基因型频率无显著差异。关联研究的汇总分析显示,5'(-318)*C纯合子的比值比为1.28(95%可信区间:1.01 - 1.63;p = 0.043),3'(514)*AT(8)等位基因的比值比为1.28(95%可信区间:1.08 - 1.51;p = 0.005)。我们在多个家系中未检测到与MS易感性的连锁关系。我们未发现与发病年龄、病程或严重程度有强关联。CTLA - 4与MS易感性相关。